Understanding analysts’ sentiment is crucial for stock investors. Yet, it’s the ongoing trend in sentiment and coverage that truly holds weight. A stock labeled as a Moderate Buy or Buy doesn’t carry much meaning if recent activity includes downgrades or lapsed coverage. These are forces that can signal a market peak and potential bearish reversals. Conversely, a stock with a Sell rating but recent upgrades speaks volumes. It signals a market bottom and potential bullish reversals.
Increased analyst coverage acts as a boon for stock prices, attracting more investor interest. Prominent stocks like Chewy and GitLab are industry leaders, destined to see their stock prices soar in line with analysts’ positive outlooks.
TD Cowen Sees Potential in Chewy, Inc.’s Long-Term Growth
Chewy’s analysts have been upping their price targets since the summer, following stellar results. MarketBeat.com reports a whopping 22 analysts backing the stock with a high rating of Buy or Moderate Buy. Most recent price forecasts are well above consensus estimates, with TD Cowen initiating coverage at Buy plus a target price of $38. This figure represents a significant 28% increase from current levels. Chewy’s revenue growth and earnings outlook have been solid, pushing the consensus estimate up by 12% in the past three months, a trend likely to continue.
Although Chewy’s growth slowed slightly in F2025, projections indicate sustained growth with acceleration expected in F2026. Analysts anticipate revenue growth to exceed 5% in F2026, with TD Cowen forecasting a robust 9% Compound Annual Growth Rate (CAGR) over the next five years. This target is nearly double the industry average, supported by a widening margin. Chewy boasts a healthy balance sheet with positive cash flow, minimal debt levels, and bullish institutional activity.
Morgan Stanley Bullish on Gitlab as Market Consolidator
Morgan Stanley has initiated coverage on GitLab with an Overweight rating and a target price of $70, signaling a 30% potential upside. The firm views GitLab’s DevSecOps platform as a critical player in consolidating a fragmented market. A projected 25% revenue CAGR over the next four years, combined with margin expansion, highlights GitLab’s prospects as software developers prioritize efficiency and security.
MarketBeat.com tracks 25 analysts with strong support for GitLab, endorsing a Moderate Buy rating. Consensus estimates point to a 23% upside from current levels, with Morgan Stanley’s price target adding a further 600 basis points. Alignment between these targets signals a positive trajectory, potentially propelling the stock to an 8-month high.